AcouSort AB today 8 June 2018 announced the signing of a License and Distribution Agreement with Instrumentation Laboratory (IL).
After the successful completion of several joint feasibility projects exploring the application of AcouSort’s proprietary ultrasound-based technology for blood/plasma separation, IL will implement the technology to enable new features in some of its in vitro diagnostics systems.
Torsten Freltoft, CEO AcouSort, comments:
”This License and Distribution agreement with IL is a major first milestone for AcouSort in commercializing our ultrasound- based separation technology. The agreement is of significant value for AcouSort, with minimum royalty payments to reach several hundred thousand euro per year, but also important as a model for future license agreements within other application fields.”